CLINICAL STUDIES ON CEFMENOXIME IN PEDIATRIC FIELD

Clinical studies in the field of pediatrics have been carried out with cefrnenoxime (CMX), a new cephalosporin antibiotic and the following results were obtained. 1.CMX was administered intravenously by drip in1fusion in 23 patients with infectious diseases. These diseases consist of 10 pneumonia, 1...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Japanese journal of antibiotics 1982/11/25, Vol.35(11), pp.2545-2554
Hauptverfasser:	OKAMOTO, KENJI, SHINO, KAZUKO, PUKE, HIAOSHI, WATANAEE, KYOKO, OZAKI, HAJIME
Format:	Artikel
Sprache:	jpn
Schlagworte:	Age Factors Cefmenoxime Cefotaxime - administration & dosage Cefotaxime - adverse effects Cefotaxime - analogs & derivatives Cefotaxime - therapeutic use Child Child, Preschool Drug Evaluation Female Humans Infant Infusions, Parenteral Male Respiratory Tract Infections - drug therapy Urinary Tract Infections - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Clinical studies in the field of pediatrics have been carried out with cefrnenoxime (CMX), a new cephalosporin antibiotic and the following results were obtained. 1.CMX was administered intravenously by drip in1fusion in 23 patients with infectious diseases. These diseases consist of 10 pneumonia, 1 bronchitis, 6 upper respiratory tract infections, 2 acute pyelitis, 3 other urinary tract infections and 1 DOUGLAS abscess. CMX was effective in all cases except 1 case of pneumonia with pyothorax. 2.No sidey effects have been observed in all cases.As for abnormal laboratory findings, 2 eases of eosinophilia, slight elevations of GOT in 3 cases and GPT in 2 cases were seen.
ISSN:	0368-2781 2186-5477
DOI:	10.11553/antibiotics1968b.35.2545